Advertisement

Topics

Nemaura Medical Announces Pricing of Up to $2.5 Million Public Offering

12:43 EST 18 Dec 2018 | Investing News Network

Nemaura Medical (NASDAQ:NMRD), a medical technology company developing sugarBEAT as a non-invasive affordable and flexible Continuous Glucose Monitor (CGM) for use by people with diabetes and pre-diabetics, today announced the pricing of a “best efforts” public offering of  Company’s shares of common stock and warrants with expected total gross proceeds of up to $2.5 million. … Continued

The post Nemaura Medical Announces Pricing of Up to $2.5 Million Public Offering appeared first on Investing News Network.

Original Article: Nemaura Medical Announces Pricing of Up to $2.5 Million Public Offering

NEXT ARTICLE

More From BioPortfolio on "Nemaura Medical Announces Pricing of Up to $2.5 Million Public Offering"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Diabetes
Diabetes is a lifelong condition that causes a person's blood sugar level to become too high. The two main types of diabetes are: type 1 diabetes type 2 diabetes In the UK, diabetes affects approximately 2.9 million people. There are a...